Adapting The Revised Self-Leadership Questionnaire to The Portuguese Context

This study aimed to adapt the Revised Self-Leadership Questionnaire (RSLQ) (Houghton and Neck in J Manag Psychol 17(8):672–691, 2002) for the Portuguese population. 720 professionals, and university and post-graduate students participated in this study. The RSLQ factorial structure was accessed through exploratory and multi group confirmatory factor analysis. From the 9 sub dimensional and 34 items original scale, only 7 sub dimensions and 21 items were preserved. The model tested through cross-validation multigroup analysis proved to be totally invariant across the groups, suggesting good model fit.info:eu-repo/semantics/publishedVersio

Psychosocial aspects of entrepreneurial potential

This study presents a theoretical model regarding the entrepreneurial potential construct, and the main psychosocial aspects that contribute towards an individual’s preparedness to engage in activities typically associated with entrepreneurship. The general question addressed in this study is: How to explain the entrepreneurial potential construct theoretically, and how to assess it empirically? This study seeks to contribute by creating an instrument (the EPAI – Entrepreneurial Potential Assessment Inventory) that can be used to measure the entrepreneurial potential construct. In this paper we present four studies on its empirical validation. The results suggest reliable scale characteristics, convergent and discriminant validity. The EPAI can be used by an entrepreneur for self-assessment, for training, and for professional development.info:eu-repo/semantics/publishedVersio

Core Performance Measures

Versão pós-print

'É melhor em conjunto': uma análise de clusters à auto-liderança e a sua relação com a inovação individual em enfermeiros hospitalares

Self-leadership is designed to influence positive outcomes like individuals’ innovative capacity in the workplace. Nevertheless, research on the relationship between self-leadership and individual innovation has failed to determine which self-leadership strategies contribute to innovation. Thus, this study aims to: explore the existence of different profiles of self-leadership strategies in hospital nurses and, test if these different profiles have different effects on individuals’ ability to be innovative. 288 nurses participated in this study. Firstly, data was analysed using Cluster analysis. Secondly, to verify the significance of the association between self-leadership clusters and individual innovation chi-square tests were conducted and the adjusted residuals were considered. Results revealed the existence of 3 different clusters of self-leadership, and that individual innovation is more frequent when all self-leadership strategies are used. The findings suggest that self-leadership strategies vary between individuals and that they all should be fostered in order to promote individual innovation.info:eu-repo/semantics/publishedVersio

Firefighters’ leadership and well-being in rural fires: study in virtual reality environments

In this study, we analysed the effects of team leadership style on the well-being of firefighter teams operating under conditions of a simulated rural fire. Twenty teams of firefighters (composed of five elements each) took part in a computer‐based fire‐fighting simulation task and were randomly assigned to one of two conditions (leadership style: directive vs. empowering). Our results showed that directive leadership style was negatively associated with team members levels of stress and anxiety, while an empowering leadership style did not have a significant effect on team members levels of stress and anxiety. The distinct effects of team leadership style remain unchanged when we controlled for the levels of stress and anxiety before the simulation. Through moderated regression analyses we observed that the effect of directive leadership styles in reducing stress and anxiety was stronger for participants with higher levels of previous stress and anxiety. Implications for theory and practice are discussed.info:eu-repo/semantics/publishedVersio

A cannabis e suas aplicações terapêuticas

Projeto de Pós-Graduação/Dissertação apresentado à Universidade Fernando Pessoa como parte dos requisitos para obtenção do grau de Mestre em Ciências FarmacêuticasUm dos grandes desafios da Química Farmacêutica prende-se com a obtenção de estruturas químicas novas que servirão como base para novos agentes terapêuticos. Durante muito tempo, as plantas foram quase exclusivas na terapia disponível para o Homem. A utilização terapêutica da Cannabis sativa ou dos seus derivados é conhecida há muitos anos, no entanto, o estudo das suas propriedades, dos seus análogos e dos recetores canabinóides (CB1 e CB2) e as enzimas envolvidas no seu metabolismo é muito recente. Após a descoberta dos canabinóides endógenos os estudos científicos focaramse na investigação do seu potencial clínico. Em alguns países, os derivados da cannabis constituem uma opção farmacológica na estimulação do apetite e no tratamento da dor. O primeiro medicamento baseado nos canabinóides endógenos um antagonista do recetor CB1, o rimonabant foi aprovado para o tratamento da obesidade, contudo este foi retirado por questões de segurança. Atualmente existem várias evidências que demonstram haver interesse clínico dos canabinóides e da sua aplicação terapêutica, contudo, os seus efeitos secundários limitam a sua aplicação e autorização. One of the great challenges of Pharmaceutical Chemistry has to do with the discovery of new chemical structures that serve as the basis for new therapeutic agents. For a long time, plants were almost exclusively available for the Man in therapy. The therapeutic use of cannabis sativa or its derivatives has been known for many years however, the study of its properties, its analogs and cannabinoid receptors (CB1 and CB2) and the enzymes involved in their metabolism is very recent. After the discovery of endogenous cannabinoids, scientific studies have focused on the investigation of its clinical potential. In some countries, derivatives of cannabis constitute a pharmacological option in the stimulation of appetite and in the treatment of pain. The first drug based on endogenous cannabinoid CB1 receptor antagonist, rimonabant has been approved for the treatment of obesity however, it was withdrawn for safety reasons. Currently there are several evidences that show that there is clinical interest of cannabinoids and their therapeutic application, however, their side effects limit its application and its permit

A cannabis e suas aplicações terapêuticas

Projeto de Pós-Graduação/Dissertação apresentado à Universidade Fernando Pessoa como parte dos requisitos para obtenção do grau de Mestre em Ciências FarmacêuticasUm dos grandes desafios da Química Farmacêutica prende-se com a obtenção de estruturas químicas novas que servirão como base para novos agentes terapêuticos. Durante muito tempo, as plantas foram quase exclusivas na terapia disponível para o Homem. A utilização terapêutica da Cannabis sativa ou dos seus derivados é conhecida há muitos anos, no entanto, o estudo das suas propriedades, dos seus análogos e dos recetores canabinóides (CB1 e CB2) e as enzimas envolvidas no seu metabolismo é muito recente. Após a descoberta dos canabinóides endógenos os estudos científicos focaramse na investigação do seu potencial clínico. Em alguns países, os derivados da cannabis constituem uma opção farmacológica na estimulação do apetite e no tratamento da dor. O primeiro medicamento baseado nos canabinóides endógenos um antagonista do recetor CB1, o rimonabant foi aprovado para o tratamento da obesidade, contudo este foi retirado por questões de segurança. Atualmente existem várias evidências que demonstram haver interesse clínico dos canabinóides e da sua aplicação terapêutica, contudo, os seus efeitos secundários limitam a sua aplicação e autorização. One of the great challenges of Pharmaceutical Chemistry has to do with the discovery of new chemical structures that serve as the basis for new therapeutic agents. For a long time, plants were almost exclusively available for the Man in therapy. The therapeutic use of cannabis sativa or its derivatives has been known for many years however, the study of its properties, its analogs and cannabinoid receptors (CB1 and CB2) and the enzymes involved in their metabolism is very recent. After the discovery of endogenous cannabinoids, scientific studies have focused on the investigation of its clinical potential. In some countries, derivatives of cannabis constitute a pharmacological option in the stimulation of appetite and in the treatment of pain. The first drug based on endogenous cannabinoid CB1 receptor antagonist, rimonabant has been approved for the treatment of obesity however, it was withdrawn for safety reasons. Currently there are several evidences that show that there is clinical interest of cannabinoids and their therapeutic application, however, their side effects limit its application and its permit

How transactive memory systems and reflexivity relate with innovation in healthcare teams

Transactive memory systems promote the effective exchange of diverse information, and may therefore contribute to healthcare teams innovation. Prior research on performance outcomes, however, suggests that transactive memory systems might be most useful for repetitive, rather than novel tasks. We reconcile these conflicting predictions by arguing that the information processing efficiencies of a transactive memory system will benefit innovation because transactive memory systems will help team members also reflecting on their processes and goals. We tested our hypotheses in a sample of 256 healthcare nurses (Nteams=54). Our findings support prior research showing that reflexivity is positively related to team innovation in teams. Furthermore, we found that reflexivity fully mediates the relationship between transactive memory systems and team innovation. This study contributes to the literature by addressing how team cognitive structures and processes combine to affect innovation. This study makes practical contributions by offering ideas for organizing in healthcare settings.info:eu-repo/semantics/publishedVersio

There Is Light and There Is Darkness: On the Temporal Dynamics of Cohesion, Coordination, and Performance in Business Teams

This study examines teams as complex adaptive systems (tCAS) and uses latent growth curve modeling to test team cohesion as an initial condition conducive to team performance over time and the mediational effect of team coordination on this relationship. After analyzing 158 teams enrolled in a business game simulation over five consecutive weeks, we found that change in team coordination was best described by a continuous linear change model, while change in team performance was best described by a continuous nonlinear change model; and the mediation latent growth curve model revealed a negative indirect effect of team cohesion on the level of change in team performance over time, through the level of change in team coordination. This study contributes to the science of teams by combining the notions of initial conditions with co-evolving team dynamics, hence creating a more refined temporal approach to understanding team functioning.info:eu-repo/semantics/publishedVersio